NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

BMY v. Inovio for DCVAX-Prostate?

(See my last post. I talk about more than just the website.)

So, if Inovio is thinking immunotherapy combos, and BMY just sold off its diabetes arm to acquire cancer therapy companies and/or platforms, and we know they are both interested in prostate immunotherapy, and they don't have much time before DCVAX-L and DC-Direct data come in and potentially jack up the asking price for DCVAX-Prostate....Hmmm.


I mentioned the possibility of BMY acquiring/partnering DCVAX-Prostate in a post I put up last night.....and serendipity would have it Dr. Kim from Inovio highlights Dendreon's prostate product weaknesses the very next day in the same breath as NWBO being dragged down by IMUC....
not giving myself credit here...just trying to say that delay on the website may be more than a bug or two. Moreover, as much as I enjoy seeing the price go up for NWBO, you gotta wonder if something is in the works, because there was no news today.

Oh, and then there is always the motivating factor of the purchaser/partner/liscensee getting the tax write-off before December.


(Here's my post title from last night before SA interviewed Dr. Kim)

Bristol Myers may be interested in DCVAX-Prostate (partnering or out right buying).